Latest Breaking News On - Department of leukemia division cancer medicine - Page 1 : comparemela.com

The approval was based on data from 2 studies of blinatumomab in adults and pediatric patients with CD19-positive B-cell precursor acute lymphoblastic leukemia.

United statesBarrettj blinatumomabDavid reeseElias jabbourEuropean unionUniversity of texas md anderson cancer centerDepartment of leukemia division cancer medicineCancer medicineCancer center